These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1362374)

  • 21. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can thyroid stimulating hormone levels by TSH (IRMA) predict relapse of thyrotoxicosis following carbimazole treatment?
    Wilson R; Semple CG; Reid AM; Glen AC; McKillop JH; Thomson JA
    Postgrad Med J; 1987 Sep; 63(743):755-6. PubMed ID: 3444799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin autoantibodies in Graves' disease--before and after carbimazole therapy.
    Armitage M; Franklyn J; Scott-Morgan L; Parr J; Borsey DQ; Sheppard M; Wilkin TJ
    Diabetes Res Clin Pract; 1990 Mar; 8(3):169-76. PubMed ID: 2340791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential immunosuppressive action of carbimazole and propylthiouracil.
    Wilson R; McKillop JH; Pearson C; Burnett AK; Thomson JA
    Clin Exp Immunol; 1988 Aug; 73(2):312-5. PubMed ID: 3263234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies of thyroid hormone and methimazole levels in patients with Graves' disease on a standardized anti-thyroid drug regimen.
    Dahlberg PA; Karlsson FA; Lindström B; Wide L
    Clin Endocrinol (Oxf); 1981 Jun; 14(6):555-62. PubMed ID: 6895351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for carbimazole as an antioxidant?
    Wilson R; Buchanan L; Fraser WD; Jenkins C; Smith WE; Reglinski J; Thomson JA; McKillop JH
    Autoimmunity; 1998; 27(3):149-53. PubMed ID: 9609132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimum duration of antithyroid drug treatment determined by assay of thyroid stimulating antibody in patients with Graves' disease.
    Edan G; Massart C; Hody B; Poirier JY; Lé Reun M; Hespel JP; Leclech G; Simon M
    BMJ; 1989 Feb; 298(6670):359-61. PubMed ID: 2564286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma thyroxine, 3,3',5-triiodothyronine and 3,3',5'-triiodothyronine during beta-adrenergic blockade in hyperthyroidism.
    Verhoeven RP; Visser TJ; Doctor R; Hennemann G; Schalekamp MA
    J Clin Endocrinol Metab; 1977 May; 44(5):1002-5. PubMed ID: 576870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid stimulating hormone receptor antibody in thyroid diseases.
    Vadivelu N; Stephen DC; Kanagasabapathy AS; Seshadri MS
    Indian J Med Res; 1990 Aug; 92():220-3. PubMed ID: 1977696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid function parameters and TSH-receptor antibodies in healthy subjects and Graves' disease patients: a sequential study before, during and after pregnancy.
    González-Jiménez A; Fernández-Soto ML; Escobar-Jiménez F; Glinoer D; Navarrete L
    Thyroidology; 1993 Apr; 5(1):13-20. PubMed ID: 7508738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time, carbimazole and the outcome of Graves' disease.
    Wilkin TJ; Beck JS; Crooks J; Isles TE; Gunn A
    J Endocrinol Invest; 1981; 4(4):409-11. PubMed ID: 6895905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyrotropin Receptor Antibody Levels at Diagnosis and After Thionamide Course Predict Graves' Disease Relapse.
    Tun NN; Beckett G; Zammitt NN; Strachan MW; Seckl JR; Gibb FW
    Thyroid; 2016 Aug; 26(8):1004-9. PubMed ID: 27266892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TSH suppression combined with carbimazole for Graves' disease: effect on remission and relapse rates.
    Pujol P; Osman A; Grabar S; Daurès JP; Galtier-Dereure F; Boegner C; Baldet L; Raye R; Bringer J; Jaffiol C
    Clin Endocrinol (Oxf); 1998 May; 48(5):635-40. PubMed ID: 9666876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid stimulating antibody: an index of thyroid stimulation in Graves' disease?
    Baldet L; Madec AM; Papachristou C; Stefanutti A; Orgiazzi J; Jaffiol C
    Acta Endocrinol (Copenh); 1987 Sep; 116(1):7-12. PubMed ID: 2889309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antithyroid drugs and Graves' disease--prospective randomized assessment of long-term treatment.
    Maugendre D; Gatel A; Campion L; Massart C; Guilhem I; Lorcy Y; Lescouarch J; Herry JY; Allannic H
    Clin Endocrinol (Oxf); 1999 Jan; 50(1):127-32. PubMed ID: 10341866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remission with carbimazole therapy & assessment of T4 suppression test as an index of relapse in patients with Graves' disease in India.
    Goswami R; Bal CS; Gupta N; Kochupillai N
    Indian J Med Res; 1996 May; 103():272-7. PubMed ID: 8707364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Graves' disease in pregnancy: TSH receptor binding inhibiting immunoglobulins and maternal and neonatal thyroid function.
    Mortimer RH; Tyack SA; Galligan JP; Perry-Keene DA; Tan YM
    Clin Endocrinol (Oxf); 1990 Feb; 32(2):141-52. PubMed ID: 1971773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
    Takamatsu J; Hosoya T; Naito N; Yoshimura H; Kohno Y; Tarutani O; Kuma K; Sakane S; Takeda K; Mozai T
    J Clin Endocrinol Metab; 1988 Jan; 66(1):147-52. PubMed ID: 3335601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triiodothyronine antibodies in a case of Graves' disease: long-term follow-up under carbimazole.
    Heshmati HM; Izembart M; Turpin G; Vallée G
    Horm Metab Res; 1991 Mar; 23(3):148. PubMed ID: 1864563
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.